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DAX-1 is an unusual member of the nuclear hormone
receptor (NHR) superfamily. Lack of DAX-1-mediated
silencing leads to adrenal hypoplasia congenita and hy-
pogonadotropic hypogonadism. Gene silencing through
NHRs such as the thyroid hormone receptor (TR) is me-
diated by corepressors. We have previously character-
ized a novel corepressor, termed Alien, which interacts
with TR and the ecdysone receptor but not with the
retinoic acid receptors RAR or RXR. Here, we show that
DAX-1 interacts with the corepressor Alien but not with
the corepressor SMRT. This interaction is mediated by
the DAX-1-silencing domain. Naturally occurring mu-
tants of the DAX-1 gene fail to interact with Alien and
have lost silencing function. Because the silencing do-
main of DAX-1 is unusual for NHRs, we mapped the
interaction of Alien with DAX-1 and with TR. We show
that Alien exhibits different binding characteristics to
DAX-1 and TR. Furthermore, Northern experiments
demonstrate that Alien is expressed in the adrenal gland
and testis in tissues where DAX-1 is specifically ex-
pressed. Interestingly, a novel adrenal gland-specific
mRNA of Alien was discovered. Thus, the impairment of
Alien binding seems to play an important role in the
pathogenesis mediated by DAX-1 mutants.
The gene superfamily of nuclear hormone receptors (NHRs)1
represents a large class of transcription factors including re-
ceptors for steroids, nonsteroids, and members for which no
ligand has yet been identified, the so-called orphan receptors
(for reviews, see Refs. 1 and 2). Gene silencing is mediated by
a few members such as receptors for thyroid hormone (TR
(NR1A)) (3) and retinoic acid (RAR (NR1B)) (4–10). Thereby,
the receptor is associated with corepressors, and the complex of
receptor and corepressors mediates target gene repression (2,
9–12). Among corepressors, N-CoR and SMRT represent one
class, and Alien represents another class, which interacts in a
hormone-sensitive manner with NHR (10–13). The silencing
domain of NHRs is localized in the C terminus and overlaps
with the hormone-binding domain to a great extent. In the case
of TR and RAR, the silencing domain encompasses 230 amino
acids (5, 14). Hormone binding by NHRs leads to a conforma-
tional change, dissociation of corepressors, subsequent binding
of coactivators, and gene activation (for review, see Ref. 15).
The transcriptional properties of nuclear receptors can be
transferred to heterologous proteins and therefore represent
functional domains (for review, see Refs. 2, 16, and 17).
DAX-1 (NR0B1) is an unusual member of the NHR super-
family (18, 19). The DNA-binding domain is unrelated to other
nuclear receptors and is composed of four repeat sequences,
which are able to recognize and bind to hairpin structures (20).
The C terminus, however, is homologous to members of the
NHR superfamily (18). Mutations in the DAX-1 gene cause the
X-linked disorder of adrenal hypoplasia congenita and the as-
sociated hypogonadotropic hypogonadism (18, 19, 21, 22).
DAX-1 is predominantly expressed in adrenal gland and
testis (18), where DAX-1 mutations strongly affect the devel-
opment and differentiation of these tissues. Expression of
DAX-1 has also been reported in hypothalamus and pituitary
(23). It has been shown that DAX-1 blocks steroidogenesis in
adrenal cells by inhibiting the expression of steroidogenic acute
regulatory protein (20). Furthermore, DAX-1 inhibits the acti-
vation function of orphan nuclear receptor SF-1, which is in-
volved in sex-specific gene expression (24–26). One mechanism
by which DAX-1 inhibits gene expression is through a potent
silencing domain localized in the C terminus (24, 27, 28). In-
terestingly, all DAX-1 mutations found in patients with adre-
nal hypoplasia congenita have the common feature of an al-
tered C terminus (27). N-CoR was shown to interact with
DAX-1 (28), while a lack of corepressor squelching using RAR
indicates that there are additional corepressors involved in
DAX-1-mediated silencing (27).
Recently, we have characterized a novel human corepressor
termed Alien according to the high homologies throughout the
entire protein (90% identity) to Drosophila Alien (13). Alien
interacts with a subset of NHRs such as TR, the ecdysone
receptor, and seven-up, the Drosophila homologue of COUP-
TF1, but not with RAR, retinoic acid X receptor, or the Dro-
sophila homologue Ultraspiracle. The lack of interaction with
RAR and the absence of significant sequence homologies with
the SMRT/N-CoR class of corepressors indicate that Alien be-
longs to a different class of corepressors, which interact in a
hormone-sensitive manner.
Based on sequence differences between the silencing domain
of DAX-1 and that of NHRs, we analyzed the interaction of the
corepressor Alien with DAX-1. Interestingly, the DAX-1 silenc-
ing domain maps to a homologous region of TR that is unable to
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mediate silencing. Here, we show that Alien interacts with
DAX-1. The interaction of Alien with DAX-1 differs from the
interaction of Alien with TR, suggesting that the corepressor
Alien uses distinct protein domains to interact with different
silencing domains. Furthermore, we identified a novel alien
mRNA species that is specific for adrenal gland. In addition,
naturally occurring DAX-1 mutants, involved in adrenal hyp-
oplasia congenita and the associated symptoms of hypogonado-
tropic hypogonadism, fail to interact with Alien and lack silenc-
ing function. These findings suggest that the DAX-Alien
complex is important in mediating the developmental function
of DAX-1.
EXPERIMENTAL PROCEDURES
Plasmids—Mammalian expression vectors for Gal-DAX, Gal-
DAX283, Gal-DAX346, and Gal-DAXD423 were generated by excision of
DAX-1 coding sequences from pSG-DAX (a generous gift from Dr. P.
Sassone-Corsi) using Eco52I, Eco255I, NaeI, and Bsp120I, respectively,
and the in-frame insertion into pABgal94 linker (9). pABgal-DAX-
R267P was generated by a three-fragment ligation using the Eco255I
DAX-1 fragment from pABgal-DAX, a synthetic oligonucleotide bearing
the mutation R267P (SalI/Eco255I ends) inserted into pABgal94 linker
SalI/Eco255I sites. pABgal-DAXD344–352 was created by deletion of
the internal BanI fragment and religation. pABgal-TR265–461 was
described earlier (29).
Yeast Expression Plasmids—The activator fusions of DAX-1 and
deletions were cloned by excision of EcoRI from the corresponding
pABgal-DAX vectors into the EcoRI site of pJG4–5 (30). plex-hAlien
fusion proteins were generated using restriction enzymes and by in-
frame insertions of the hAlien cDNA from pABgal-hAlien (13) into
pEG202 (30). Full-length plex-SMRT (10) was generated by insertion of
the EcoRI fragment from pCMX-gal-SMRT (a generous gift from Dr. R.
Evans) into the EcoRI site of pEG202.
Cell culture, yeast two-hybrid assay, and GST pull-down experi-
ments were performed as described previously (13, 31). For yeast two-
hybrid experiments the C terminus of TRb (amino acids 173–461) was
used as the activator (fusion to the B42 activation domain, Ref. 30).
Similarly, the DAX-1 C terminus was used as the activator, and hAlien
was used as the bait (lexA fusion). For DNA transfection experiments 1
pmol of pABgal94 linker (9) or pABgal-DAX fusion expression plasmids
and 1.5 pmol of 17mer6x-tkCATDH/N reporter (5) were used for CaPO4
transfection experiments (31). In Fig. 3 the basal promoter activity
resulted in 26% chloramphenicol acetyltransferase conversion, which
was reduced to 2.75% with DAX-1. For in vitro translation of full-length
DAX-1 the vector pSG-DAX was used with the TNT coupled reticulocyte
lysate system (Promega) according to the manufacturer’s protocol. Co-
immune precipitations were performed using polyclonal anti-hemagglu-
tinin (HA) antibody (Santa Cruz Biotechnology) bound to protein A-
Sepharose beads (Amersham Pharmacia Biotech) with extracts derived
from 293 cells transfected with expression vectors encoding HA alone or
HA-hAlien together with AU5-tagged DAX-1 C terminus (amino acids
245–470). 293 cells were lysed with 0.1% Nonidet P-40, 50 mM Tris, pH
7.5, 450 mM NaCl, 1 mM dithiothreitol, and 0.2 mM phenylmethylsulfo-
nyl fluoride. After centrifugation at 4 °C extracts were diluted with
water 1:1 and incubated for 4 h with anti-HA antibody. After several
washing steps the precipitates were analyzed by SDS-polyacrylamide
gel electrophoresis. Western blotting was performed with the ECL kit
(Amersham Pharmacia Biotech) using mouse anti-AU5 antibody
(Berkeley Antibody) and peroxidase-coupled anti-mouse antibodies
(Amersham Pharmacia Biotech).
RNA Extraction and Northern Analysis—Total RNA from tissues of
adult Wistar rats was isolated via the guanidinium isothiocyanate/
phenol/chloroform procedure. 60 mg of total RNA obtained from each
tissue was used. Radiolabeled halien cDNA (KpnI/BamHI fragment of
pAB-hAlien) (13) was used as a probe with the random priming proce-
dure. As controls, blots were stained with 0.3 M sodium acetate plus
0.02% methylene blue to check RNA integrity and rehybridized for
normalization (NIH image program) with a radiolabeled cyclophilin
cDNA probe (32).
RESULTS
DAX-1 Interacts with the Corepressor Alien—We have re-
cently characterized a novel corepressor for specific members of
the NHR superfamily (13). Because DAX-1 is able to mediate
silencing (24, 27, 28), we wanted to know whether Alien inter-
acts with the silencing domain of DAX-1. For this purpose we
used the yeast two-hybrid system (30). As bait, human Alien
(lex-Alien) was used, and as activator, DAX-1 (amino acids
245–470) as a DAX-B42 fusion protein was used. As seen in
Fig. 1A, the corepressor Alien (full-length) interacts with the
DAX-1 silencing domain (amino acids 245–470). The obtained
b-galactosidase units (Miller units) are similar in magnitude to
that seen with Alien and TR. In comparison, using the full-
length SMRT corepressor (10) we observed no detectable inter-
action of SMRT with DAX-1, whereas full-length SMRT inter-
acts with TR (Fig. 1A).
Furthermore, we performed GST pull-down assays using
bacterially expressed GST-hAlien fusion protein and in vitro
translated, 35S-labeled full-length DAX-1 (Fig. 1B). As controls
GST alone and 35S-labeled luciferase were used. As expected,
DAX-1 specifically interacts with hAlien in vitro (Fig. 1B).
To analyze interaction of Alien with DAX-1 in mammalian
cells we performed co-immune precipitation experiments with
transfected 293 cells. Each of the expression vectors coding for
HA as control or HA-tagged Alien (HA-Alien) was cotransfected
with AU5-tagged DAX-1. Anti-HA antibody was used for pre-
cipitations. The anti-AU5 antibody was used for detection in
Western analysis showing that DAX-1 co-immunoprecipitates
with hAlien (Fig. 1C). Thus, the corepressor Alien interacts
with the transcriptional silencer DAX-1.
DAX-1 Has an Unusual Silencing Domain within the NHR
FIG. 1. The corepressor Alien but not SMRT interacts with
DAX-1. A, yeast two-hybrid experiments with either full-length Alien or
SMRT (10) as bait and DAX-1 or thyroid hormone receptor b (TR) as the
activator reveal that Alien binds to both DAX-1 and TR, whereas
full-length SMRT lacks interaction with DAX-1. Miller units represent
the b-galactosidase units obtained from the reporter. B, GST pull-down
experiments were performed with bacterially expressed GST-hAlien
and in vitro translated and 35S-labeled full-length DAX-1. As controls
35S-labeled luciferase was mixed with the DAX-1 in vitro translate. C,
co-immunoprecipitation experiments were performed using polyclonal
anti-hemagglutinin antibody and extracts of 293 cells cotransfected
with expression vectors coding for AU5-tagged DAX and either HA tag
alone (HA) or hemagglutinin-tagged Alien (HA-Alien). Western blotting
was performed with the AU5 antibody. WCE, whole cell extract.
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Family—The silencing domain of TR and that of the closely
related v-ErbA oncogene product are localized in the receptor C
terminus and have been well characterized (5, 14, 29, 33). This
domain encompasses 230 amino acids that include helices 1–11
of the receptor C terminus. Deletion of either helix 1 or 11
abrogates silencing function.
We aligned the amino acid sequence of the silencing domains
of DAX-1, TR/v-ErbA, and RAR (Fig. 2). In addition, we indi-
cated the amino acid borders of the TR/v-ErbA silencing do-
main and deletion end points that have lost silencing function
(5, 14, 29).
Interestingly, the C terminus of DAX-1, which harbors the
silencing domain, is unusual compared with TR and RAR (Fig.
2). Sequence alignment of TR, RAR, and DAX-1 shows that the
striking characteristic of DAX-1 is an unusual insertion C-
terminal to the Ti region. Furthermore, the N-terminal border
of the DAX-1 silencing domain correlates with a region of TR
that is not sufficient either to mediate gene silencing (Fig. 2
and Refs. 5, 14, and 29) or to interact with hAlien (13). This
raises the question of how Alien is able to interact with DAX-1.
Loss of the Silencing Function of DAX-1 Correlates with Loss
of Interaction with Alien—To investigate whether the Alien-
DAX-1 interaction correlates with the silencing function of
DAX-1, we tested DAX-1 mutants in reporter and interaction
assays. Expression plasmids coding for Gal-DAX fusion pro-
teins were cotransfected along with the reporter 17mer6x tk-
CAT into mouse L-cells. The C terminus of DAX-1 (amino acids
245–470) silences gene transcription in these cells (Fig. 3). In
contrast, the homologous region of TR/v-ErbA does not mediate
silencing (Fig. 3). Deletion of only 38 amino acids (DAX 283–
470), which deletes part of the Ti region and the entire putative
helix 3, abrogates this silencing function. Similarily, premature
stop codons found in patients with hypogonadism and adrenal
hyperplasia (19, 34–37), represented here by a C-terminal de-
letion (245–423), also result in loss of silencing. A patient-
derived DAX-1 mutant having a one-amino acid exchange,
R267P (19), in the Ti region lacks silencing function as seen
previously (27).
One reason DAX-1 is able to mediate silencing whereas the
homologous part of TR is not may be the insertion of additional
amino acids C-terminal of the Ti region of DAX-1. Therefore,
we generated an internal deletion mutant (D344–352). How-
ever, this deletion does not affect the silencing activity (Fig. 3),
indicating that these amino acids within the insertion are not
critical for gene silencing.
Next, we wanted to analyze the interaction of Alien with
these DAX-1 mutants lacking silencing. Whereas the wild-type
DAX-1 interacts with Alien, the DAX-1 mutants R267P or DAX
245–423 do not exhibit a detectable interaction (Fig. 4). Thus,
the interaction of Alien with DAX-1 correlates with the silenc-
ing function of DAX-1, and mutants of DAX-1 fail to interact
with Alien.
FIG. 2. The DAX-1 silencing domain is unusual in that the homologous regions of TR or RAR are unable to mediate gene silencing.
Sequence alignment of the silencing domains of DAX-1 with TRa, TRb, v-ErbA, and RARa reveal that the DAX-1 silencing domain is shorter than
those of TR or RAR and that DAX-1 has an unusually long insertion C-terminal to the Ti region. Arrows indicate the borders of the silencing
domains and the deletion end points, which abrogate silencing of TR/RAR or DAX-1. AF2-AD/t4/tc indicates the activation domain identified in
TR and RAR that is essential for corepressor dissociation and coactivator binding. The Ti-region has been identified as a very conserved region in
NHRs. The R267P mutation, localized in the Ti-region, and the part of TR (D265) homologous to DAX-1 are indicated. The alignment is based on
the multiple alignment program (MAP) and the alignments of Zanaria et al. (18) and Lalli et al. (27).
Interaction of the Corepressor Alien with DAX-17664
 at UQ Library on October 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Alien Interacts Differentially with DAX-1 and TR—Because
the TR part that is homologous to the DAX-1 silencing domain
does not mediate silencing and does not bind to Alien, we
wanted to investigate which regions of Alien are required for
binding of Alien to either TR or DAX-1. We generated deletions
of human Alien and tested them for interaction with DAX-1
and TR in yeast two-hybrid assays (Fig. 5). The N-terminal
deletion of Alien (amino acids 128–305) is able to bind to TR,
whereas the interaction with DAX-1 is almost undetectable.
Conversely, only a 30-amino acid C-terminal deletion of Alien
(amino acids 1–275) fails completely to interact with TR, but it
shows strong binding to DAX-1. This suggests that the C ter-
minus of Alien is essential for binding to TR, although not
sufficient, as shown by using other Alien deletion mutants (Fig.
5). Conversely, the N-terminal part of Alien is essential but not
sufficient for binding to DAX-1. Thus, DAX-1 and TR interact
with different regions of Alien.
Alien and DAX-1 Are Coexpressed in Adrenal Gland—DAX-1
is expressed specifically in the adrenals and testes, and muta-
tions in the DAX-1 gene affect the development and differenti-
ation of these tissues. Therefore, we tested whether Alien is
also expressed in these tissues. Northern experiments were
performed with total RNA from rat testis and adrenals using
alien cDNA as a probe. Northern blot analysis (Fig. 6) revealed
one major Alien-specific band at about 2 kb in testis, a result
that is in agreement with Schaefer et al. (38), whereas various
other tissues show two bands migrating at 2 and 4 kb. How-
ever, in adrenals two Alien-specific bands are observed migrat-
ing at 2 and 4 kb, and a third Alien-specific band, which is novel
yet undescribed, migrates at 6 kb (Fig. 6). Thus, Alien is co-
expressed with DAX-1 in testis and adrenal gland.
DISCUSSION
Here, we show that the corepressor Alien interacts with the
orphan receptor DAX-1. The interaction occurs in the DAX-1 C
terminus. Importantly, all DAX-1 mutations found in patients
with adrenal hypoplasia congenita have the common feature of
an altered C terminus (27).
Mutants of thyroid hormone receptor b are involved in the
disease of thyroid hormone resistance. Patients manifest vari-
ous degrees of delay of bone development, hearing defects, and
mental retardation. In these cases receptor mutants have re-
duced or completely lost the hormone-dependent activation but
FIG. 3. The silencing domain of DAX-1 is unusual. Cotransfec-
tion experiments were performed in mouse L-cells using expression
plasmids encoding for the C terminus of DAX-1 fused to the Gal4-DBD
and the reporter 17mer6x tkCAT. The DAX-1 C terminus harbors a
transferable silencing function that is abolished through C- and N-
terminal deletions as well as through the natural point mutant R267P
isolated from a patient with X-linked adrenal hypoplasia congenita, but
this silencing function is not abrogated in the mutant DAXD345–352,
deleting eight amino acids in the unusual insertion (Fig. 2). aa, amino
acids.
FIG. 4. Naturally occurring DAX-1 mutants are unable to in-
teract with Alien. Yeast two-hybrid experiments were performed with
DAX-1, the C-terminal deletion DAXD423, and DAX R267P as activator
fusion proteins and full-length hAlien as the bait. Values obtained in
the absence of hAlien were set arbitrarily as one.
FIG. 5. Alien interacts in a different manner with TR than it
does with DAX-1. Various deletions of hAlien were tested for interac-
tion with TR or DAX-1 in yeast two-hybrid experiments. Deletion of
only the C-terminal 30 amino acids of Alien results in a mutant that
specifically interacts with DAX-1, whereas an N-terminal deletion mu-
tant selectively interacts with TR.
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have retained silencing function (17, 39). Accordingly, corepres-
sors remain bound to the receptor’s silencing domain even in
the presence of ligand (40). However, mutations of the DAX-1
gene result in mutants lacking silencing function and interac-
tion with the corepressor Alien. Thus, unlike thyroid hormone
resistance, the disease of adrenal hypoplasia congenita and the
associated hypogonadism result from a lack of corepressor in-
teraction and transcriptional silencing (27).
Our failure and the failure of others to observe a significant
interaction of SMRT with DAX-1 indicate that DAX-1 binds to
a subset of corepressors. Also, Alien interacts with a subset of
nuclear receptors that is distinct from the subset bound by the
corepressor SMRT. Furthermore, Alien does not bind to the C
terminus of RARa (13), whereas SMRT/N-CoR does. Thereby,
the small activation domain AF2-AD/t4/tc of RAR prevents the
binding of Alien, providing a new role for AF2-AD/t4/tc of
regulating the binding of corepressors in the absence of ligand.
Thus, Alien interacts differentially with the silencing domains
of different nuclear receptors. Alien’s lack of interaction with
RAR may also explain the inability of RAR to relieve silencing
mediated by DAX-1 in squelching experiments (27).
It is noteworthy that the extension of the DAX-1 silencing
domain is different from that of other nuclear receptors such as
TR or RAR. Interestingly, homologies in the amino acid se-
quence between the DAX-1 silencing domain and TR or RAR
are found to be in a region of TR or RAR that is unable either
to mediate gene silencing or to interact with corepressors (5, 10,
12–14, 29, 33). Thereby, the silencing domain of DAX-1 is
homologous to the region of TR that excludes a major part of
the hinge region required for interaction of TR with the core-
pressors SMRT/N-CoR and Alien. This is in agreement with
our observation that the interactions of DAX-1 and TR with
Alien are mediated through different domains.
Squelching of cofactors is efficiently performed when both
the silencer factor and the overexpressed squelcher bind the
same site on the cofactor. Alien interacts in a different manner
with DAX-1 than it does with TR (Fig. 7), a difference that may
explain the lack of significant squelching of DAX-1-mediated
silencing by TR/v-ErbA (not shown). It is also noteworthy that
overexpression of the silencing domain of DAX-1 does not com-
pletely relieve its own silencing function (Ref. 27 and data not
shown), which may indicate that DAX-1 also uses other non-
corepressor-mediated pathways for gene silencing.
Alien is expressed very early in development and in a large
number of tissues, albeit at different levels (38). Strong expres-
sion is observed in heart, brain, liver, skeletal muscle, kidney,
and testis. Interestingly, multiple RNA species have been iden-
tified. In heart and skeletal muscle, two Alien mRNA species at
2 and 4 kb are seen, whereas in liver an additional 1.8-kb form
is expressed. In testis only the 2-kb form is found (38). We show
here that in adrenal glands, in addition to the 2- and 4-kb
bands, a novel 6-kb RNA is expressed. The role of the tissue-
specific RNA messages is unclear. However, there are several
Alien protein forms. Whereas the Alien corepressor is com-
posed of 305 amino acids, there are also other forms encoding a
longer variant of Alien (Ref. 38 and data not shown). It is
possible that different forms of the Alien protein may exhibit
distinct interaction patterns with nuclear receptors.
When these results are taken together, they suggest that the
presence of the corepressor Alien may be important in the
developmental role of DAX-1 in testis and adrenals. Mutations
in the DAX-1 gene that lead to adrenal hypoplasia congenita
and hypogonadism inhibit the formation of the DAX-Alien com-
plex and lack silencing function. Therefore, we suggest that the
transcriptional repression mediated by DAX-1 through binding
to Alien plays an important role in the natural development of
the adrenal gland and testis.
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